ReviewJournal of clinical medicine2024
High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy.
Natasha V Persaud et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it